3rd Microbiome Movement – Drug Development 2019
Novotel Paris Est 1 Avenue de la République,, Bagnolet,Despite the scientific communities progress in translating microbiome R&D into promising therapeutic candidates, academic and pharmaceutical leaders continue to identify the causal role of the human microbiome in disease to create treatments with consistent clinical outcomes and predictable molecular mechanisms. Part of the established Microbiome Movement, the 3rd Microbiome Movement – Drug Development Europe returns as the industry-defining forum to help discover, develop and deliver the next generation of [...]